title: Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
authors.forename: E
authors.initials: E
authors.lastname: Ishii
authors.forename: A
authors.initials: A
authors.lastname: Matsuzaki
authors.forename: Y
authors.initials: Y
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Miyazaki
authors.forename: K
authors.initials: K
authors.lastname: Ueda
mesh_terms: D015250:Aclarubicin / Q000031:analogs & derivatives*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002675:Child, Preschool; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D009279:Naphthacenes / Q000627:therapeutic use
chemical_list: D009279:Naphthacenes; C011157:aclacinomycins; D003561:Cytarabine; D015250:Aclarubicin; C015019:enocitabine